US Patent 10766958 Methods of treating vitiligo using PD-1 binding antibodies
Patent 10766958 was granted and assigned to Celgene on September, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10766958 Methods of treating vitiligo using PD-1 binding antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.